Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays

SLAS DISCOVERY(2024)10.1016/j.slasd.2024.01.006Source: DataRank Database

Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays is a research paper published in SLAS DISCOVERY (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.44)OA: goldTopics (33)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Margarita Rzhetskaya,Ted Ling-Hu ORCID,Ramón Lorenzo-Redondo ORCID,Kelly E. R. Bachta ORCID,Karla J. F. Satchell ORCID

Live enrichment

PubMed:38301954 PMC:PMC11160173 OpenAlex:https://openalex.org/W4391451085

NIAID NIH HHS

Grant: HHSN272201700060C

NIAID NIH HHS

Grant: U19 AI135964

NIAID NIH HHS

Grant: U19 AI171110

NIAID NIH HHS

Grant: 75N93022C00035

NCI NIH HHS

Grant: P30 CA060553

National Institute of Allergy and Infectious Diseases

National Cancer Institute

FWCI

1.44

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://slas-discovery.org/article/S2472555224000078/pdf

publisherhttp://slas-discovery.org/article/S2472555224000078/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2472555224000078?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2472555224000078?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.slasd.2024.01.006

Fields of Study

CRISPR and Genetic EngineeringSARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiology

MeSH Terms

COVID-19SARS-CoV-2Antiviral AgentsHumansMethyltransferasesMutationRNA, Double-StrandedRNA, ViralVirus ReplicationViral Nonstructural ProteinsRNA Helicases

Keywords

HelicaseRNA silencingRNARNA Helicase ADuplex (building)ChemistryBiologyBiochemistryMolecular biologyDNARNA interferenceGeneDirect-acting AntiviralAntiviral Drug DiscoveryNsp13Covid-19Sars-cov-2R392cUnwinding Assay

Sustainable Development Goals

SDG 0: Good health and well-being

Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays

FAIR Checklist

Authors (7)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)